VialsRx
- 503A
“We partner with a trusted, US-based compounding pharmacy — VialsRx — that operate in full compliance with FDA guidelines and USP 797 sterile compounding standards.”
Source: trycurve.co · Verified 2026-07-20
Curve Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: compounded semaglutide or tirzepatide with flat per-dose pricing, LegitScript-certified, all 50 states
7.2
★★★★☆3.6/5
Curve is a solid telehealth option with balanced features and pricing.
$175/mo
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
See plans →See plans at Curve →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
Curve (Try Curve LLC) is a telehealth platform offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A compounding pharmacy. Care is questionnaire-based with provider review within 24 hours—no video visit. Pricing is tiered by commitment: semaglutide $99–$175/mo and tirzepatide $135–$225/mo, each plan including the consultation, prescription, medication, and free expedited shipping with no membership. All doses cost the same. Insurance isn't accepted; HSA/FSA welcome. LegitScript-certified.
By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
LegitScript CertifiedSemaglutideTirzepatideAll 50 statesFlat dose pricingNamed pharmacy VialsRxHSA/FSA acceptedNo membership fee
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Curve
★★★★☆4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →★★★★☆4/5
Editorial score · methodology
$149/mo
CompoundedSemaglutideTirzepatideOrforglipronMetformin + naltrexone + topiramate
Get StartedRead full ShedRx review →★★★★☆4.1/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full bmiMD review →Curve at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $175/mo (Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. All doses priced the same.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Consult · Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Curve
Each dimension is scored algorithmically from Curve’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.1/10At $175/mo, Curve runs in line with the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.3/10Curve offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.5/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy; discloses which pharmacy makes its medication (last checked 2026-07-20).
Accessibility10%
7.9/10Curve treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
5.1/10Curve provides standard clinician follow-up; no extended coaching or community program is disclosed.
6scored dimensions
534providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Curve review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Verified the compounding pharmacy partner and its accreditation
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Curve offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
MonthlyCompounded
$175/mo
semaglutide
Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. All doses priced the same.
MonthlyCompounded
$225/mo
tirzepatide
Month-to-month; drops to $199/mo (quarterly), $175/mo (6-month), or $135/mo on annual prepay. All doses priced the same.
Ready to get started?
Plans and promotions change often — check Curve's current pricing and active discounts before you decide.
Curve compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Curve routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
What we like
- Offers both compounded semaglutide and tirzepatide, with every dose priced the same so cost does not rise as you titrate up.
- LegitScript-certified (seal #51079066) and names both its 503A compounding pharmacy, VialsRx, and its provider network, Beluga Health.
- Transparent tiered pricing with a real month-to-month option; consultation, medication, and free expedited shipping included, no membership.
- Available in all 50 states with same-day provider review; no insurance needed and HSA/FSA accepted.
Watch-outs
- Very new (2026 launch) with a thin track record; the site still shows a Webflow template credit and a leftover Cora reference in its Terms.
- The cheapest headline rates ($99 semaglutide / $135 tirzepatide) require a 12-month prepay; true month-to-month is $175 and $225.
- Both product pages currently display an out-of-stock status, so availability may be inconsistent.
- Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.
Is Curve worth it? Our verdict
Curve positions itself around one thing: compounded semaglutide or tirzepatide with flat per-dose pricing, LegitScript-certified, all 50 states. It runs $175/month, flat across every dose. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Curve rounds out its offering with LegitScript Certified, Flat dose pricing, and Named pharmacy VialsRx.
How much Curve actually costs
- Compounded semaglutide — $175/month
- Compounded tirzepatide — $225/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
For a direct comparison, Breeze Meds runs semaglutide and tirzepatide from $169/month — worth pricing against Curve before you commit.
Medications: what Curve prescribes
Curve prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Curve is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Curve treats patients in all 50 states, dispenses through an accredited compounding pharmacy, and names the pharmacy that fills its prescriptions. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Curve is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, DudeMeds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Curve is a solid telehealth option with balanced features and pricing.
Score: 7.2/10Best for: compounded semaglutide or tirzepatide with flat per-dose pricing, LegitScript-certified, all 50 statesFrom: $175/mo
Ready to start with Curve?
Starting at $175/month. See current pricing and start your free consultation.
Curve might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider ShedRx.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Curve review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Curve's current pricing
Plans start at $175/month. Start your free consultation to check eligibility and today's price.
Not sold on Curve?
Vetted alternatives